Subnavigation

• Influenza
• Surveillance and monitoring
  • Updates
  • FluID
• GISRS and laboratory
  • FluNet
  • National Influenza Centres
  • WHO Collaborating Centres for influenza and Essential Regulatory Laboratories
  • WHO H5 Reference Laboratories
  • Antiviral susceptibility surveillance
  • WHO External Quality Assessment Project
  • Shipping and logistic activities
• PIP Framework
  • Advisory Group
  • Virus Sharing
  • Benefit Sharing
• Vaccines
  • Vaccine viruses
  • Vaccine use
• Patient care
  • Clinical management
  • Antivirals
• Human animal interface
  • Avian influenza in humans
  • Swine influenza in humans
• Public health preparedness
• Information resources
  • Research
  • Training
  • Publications

Antivirals - relevant documentation

Guidelines/recommendations

• WHO guidelines for pharmacological management of pandemic A(H1N1) 2009 influenza and other influenza viruses
  26 February 2010

Antivirals in pandemic preparedness and planning

• Open-Ended Working Group of Member States on Pandemic Influenza Preparedness: Sharing of Influenza Viruses And Access To Vaccines And Other Benefits
• WHO Interim Protocol: Rapid operations to contain the initial emergence of pandemic influenza
• WHO guidelines on the use of vaccines and antivirals during influenza pandemics (2004)

Effectiveness of antivirals

• Weekly Epidemiological Record (WER), vol 86, 45 (p497–508): Global monitoring of antiviral resistance in currently circulating influenza viruses
  pdf, 864kb
  4 November 2011
• Weekly Epidemiological Record (WER), vol. 85, 6 (p037-048): Update on oseltamivir resistant pandemic A(H1N1) 2009 influenza virus
  pdf, 273kb
  5 February 2010
• Weekly Epidemiological Record (WER), vol. 84, 44 (p453–468): Oseltamivir-resistant pandemic A(H1N1) 2009 influenza virus
  pdf, 836kb
  30 October 2009